Two Different Approaches During Fluoroscopically Guided Interlaminar Lumbar Epidural Steroid Injection
Completed · Not applicable
Conditions studied: Unilateral Lumbosacral Radiculopathy Pain
In brief
The purpose of this study is to compare two different approaches (midline and parasagittal) during interlaminar lumbar epidural steroid injection (LESI), and to verify the role of concordant pressure paresthesia occurring during the LESI in determining outcome. The investigators are planning to include 100 patients, undergoing LESI for radicular low back pain. This will be single-blinded randomized study. Every patient will receive the same medication we would use regardless of participating in the study. The patients will be randomly assigned to one of two groups, based on the approach: * Group I (50 patients) - will get LESI using midline (MIL) approach. * Group II (50 patients) - will get LESI using parasagittal interlaminar (PIL) approach.
Key facts
- Study ID
- NCT01760317
- Run by
- Kenneth D Candido
- People needed
- 106
- Starts
- 2010-08-01
- Expected to finish
- 2013-05-01
- Last updated by the study team
- 2015-02-05
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18- 80 years old
- History of low back pain and unilateral lumbosacral radiculopathy pain
- Lumbar disk disease including disk herniations, bulging discs, and degenerated discs, where at least 50% of the disk height is preserved respective to contiguous levels
You may not qualify if…
- Discogenic pain without radiculopathy pain
- History of previous spinal surgery
- LESI(s) in the past year
- Allergy to methylprednisolone, or lidocaine, or iodine-based contrast
- Concurrent use of systemic steroid medications
- Opioid habituation
- Pregnancy
Where it is running
- Chicago Anesthesia Pain Specialits — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.